ArticleJournal of the National Medical Association2006
Physician-patient discussions about prostate-specific antigen test use among African-American men.
Article in Journal of the National Medical Association, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Predictors of new screening for African American men participating in a prostate cancer educational program.Journal of cancer education : the official journal of the American Association for Cancer Education · 2009Trial
- Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.Journal of community health · 2011Article
- Discussions about prostate cancer screening between U.S. primary care physicians and their patients.Journal of general internal medicine · 2011Article
- Factors influencing prostate cancer screening in African American men.Western journal of nursing research · 2010Article
- Knowledge, beliefs and barriers associated with prostate cancer prevention and screening behaviors among African-American men.Journal of the National Medical Association · 2006Article
- Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System.American journal of men's healthArticle
- Shared decision making in prostate-specific antigen testing with men older than 70 years.Journal of the American Board of Family Medicine : JABFMArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose of this study was to examine the associations between physician-patient discussions, demographic and health-related variables, and PSA test use. Of the previous studies that examined physician-patient discussions about PSA test use, none focused on African-American men.
methodsUsing a sample of African-American men (N=739) aged > or = 40 years who had participated in the National Health Interview Survey (NHIS) 2000, we assessed demographic, health status and other variables related to two PSA test use outcomes: 1) had a PSA test within the past year, and 2) had > or = 3 PSA tests within the past five years.
resultsMore than three-fourths (76.6%) of our sample reported that their doctors had discussed with them the advantages and disadvantages of the PSA test before administering it. The bivariate analysis showed a number of variables positively associated with PSA test use including men aged > or = 50, having health insurance coverage and having participated in physician-patient discussions about the test. DISCUSSION: Despite the high percentage of men who had discussions with their doctor, there was a large number of men who had neither heard of nor undergone a PSA test. More efforts should be made by the healthcare community to promote prostate cancer screening education and physician-patient discussions.
Indexed as
Identifiers
16623065PMC2569217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.